samedan logo
 
 
spacer
home > epc > winter 2003 > translating the pharma industry
PUBLICATIONS
European Pharmaceutical Contractor

Translating the Pharma Industry

The value of translations produced in the UK is thought to be worth more than £161 million according to some definitive research carried out last year. This figure may seem relatively low value compared with the market worth of the pharmaceutical sector as a whole, but considering the volume of actual translation jobs needed to produce such a global figure, translation is far from being an insignificant net contributor to UK plc.

Let's get the rest of the statistics out of the way. The translation profession is split into two segments; companies, of which there are around 1,500, and individual freelancers. It is estimated that there are around 8,000 to 9,000 freelance translators, although there are probably more since many individuals who offer translation or interpreting services rarely join one of the recognised professional bodies. The Association of Translation Companies is the only body regulating the company sector of the profession.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Geoffrey Bowden, General Secretary of the Association of Translation Companies

Geoffrey Bowden has been the General Secretary of the Association of Translation Companies for 23 years. In addition to his role with the ATC, he runs a successful PR consultancy, Nexus Structured Communications, specialising in the health sector. The client base of the consultancy includes household names in the pharmaceutical industry.

spacer
Geoffrey Bowden
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Inaugural Conference on Pre-Filled Syringes

21-22 January 2009, Crowne Plaza Hotel - St James, London, UK

SMi present their Inaugural Conference on Pre-Filled Syringes 21st and 22nd January 2009 at the Crowne Plaza Hotel - St James, London, UK
More info >>

 
News and Press Releases

Azopharma Product Development Group, Inc

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement